M Kazim Panjwani

6PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 30, 2024
Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome.

Kyle B Lupo, M Kazim Panjwani, Sanam Shahid

|Aug 19, 2024
Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.

Jean-Benoît Le Luduec, Theodota Kontopoulos, M Kazim Panjwani

|Oct 04, 2023
Single-Cell Profiling Reveals a Naive-Memory Relationship between CD56 bright and Adaptive Human Natural Killer Cells.

M Kazim Panjwani, Simon Grassmann, Rosa Sottile

|Jun 16, 2023
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.

Sanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec

|Sep 24, 2021
Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity.

Rosa Sottile, M Kazim Panjwani, Colleen M Lau

Pageof 1